Galectin-1 promotes human neutrophil migration

Glycobiology

Volumn 23, Issue 1, 2013, Pages 32-42

  Auvynet, Constance ^a,b   Moreno, Samadhi ^a   Melchy, Erika ^a   Coronado Martínez, Iris ^a   Montiel, Jose Luis ^a,c   Aguilar Delfin, Irma ^a,d   Rosenstein, Yvonne ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^d INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

CD43; chemotaxis; galectin 1; MAPK; neutrophil; polarization

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CHEMOATTRACTANT; G PROTEIN COUPLED RECEPTOR; GALECTIN 1; LEUKOSIALIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

ANTIGENS, CD43; CHEMOTAXIS, LEUKOCYTE; GALECTIN 1; HUMANS; IMMUNITY, INNATE; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84870007788     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws128     Document Type: Article

References (80)

1. Aguilar-Delfin I, Fierro NA, Rosenstein Y. 2006. CD43 molecular page. UCSD-Nature Molecule Pages, doi:10.1038/mp.a000565.01.
2. Alge CS, Priglinger SG, Kook D, Schmid H, Haritoglou C, Welge-Lussen U, Kampik A. 2006. Galectin-1 influences migration of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 47:415-426. (Pubitemid 46780843)
3. Almkvist J, Dahlgren C, Leffler H, Karlsson A. 2002. Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. J Immunol. 168:4034-4041. (Pubitemid 34298409)
4. Alvarado M, Klassen C, Cerny J, Horejsi V, Schmidt RE. 1995. MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation. Eur J Immunol. 25:1051-1055.
5. Amano K, Takase M, Ando A, Nagata Y. 2003. Production of functional lectin in Pichia pastoris directed by cloned cDNA from Aleuria aurantia. Biosci Biotechnol Biochem. 67:2277-2279. (Pubitemid 39251692)
6. Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M, Seilhamer JJ. 1995. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med. 181:877-887.
7. Boyum A. 1968. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 97:31-50.
8. Brewer CF, Miceli MC, Baum LG. 2002. Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol. 12:616-623. (Pubitemid 35449069)
9. Burton JL, Bank HL, Law P. 1987. Kinematic analysis of chemotaxis of fresh and stored neutrophils. Ann Clin Lab Sci. 17:398-411. (Pubitemid 18047405)
10. Camby I, Le Mercier M, Lefranc F, Kiss R. 2006. Galectin-1: A small protein with major functions. Glycobiology. 16:137R-157R. (Pubitemid 44530693)
11. Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muinos FX, Fresno M, Sanchez-Madrid F. 1991. Down-regulation by tumor necrosis factoralpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol. 21:3045-3048.
12. Cooper DN, Barondes SH. 1999. God must love galectins; he made so many of them. Glycobiology. 9:979-984. (Pubitemid 29473954)
13. Cooper D, Norling LV, Perretti M. 2008. Novel insights into the inhibitory effects of galectin-1 on neutrophil recruitment under flow. J Leukoc Biol. 83:1459-1466. (Pubitemid 351960327)
14. Cross AS, Wright DG. 1991. Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells. J Clin Invest. 88:2067-2076.
15. Daniels MA, Hogquist KA, Jameson SC. 2002. Sweet 'n' sour: The impact of differential glycosylation on T cell responses. Nat Immunol. 3:903-910. (Pubitemid 35154002)
16. Dehghani Zadeh A, Seveau S, Halbwachs-Mecarelli L, Keller HU. 2003. Chemotactically-induced redistribution of CD43 as related to polarity and locomotion of human polymorphonuclear leucocytes. Biol Cell. 95:265-273. (Pubitemid 37063286)
17. Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:733-739. (Pubitemid 32144520)
18. Deng X, Ueda H, Su SB, Gong W, Dunlop NM, Gao JL, Murphy PM, Wang JM. 1999. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood. 94:1165-1173. (Pubitemid 29380396)
19. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD. 2003. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem. 278:41282-41293. (Pubitemid 37280956)
20. Elola MT, Chiesa ME, Fink NE. 2005. Activation of oxidative burst and degranulation of porcine neutrophils by a homologous spleen galectin-1 compared to N-formyl-L-methionyl-L-leucyl-L-phenylalanine and phorbol 12-myristate 13-acetate. Comp Biochem Physiol B Biochem Mol Biol. 141:23-31. (Pubitemid 40463251)
21. Fukuda M, Carlsson SR. 1986. Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens. Med Biol. 64:335-343. (Pubitemid 17226776)
22. Fulcher JA, Chang MH, Wang S, Almazan T, Hashimi ST, Eriksson AU, Wen X, Pang M, Baum LG, Singh RR, Lee B 2009. Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. J Biol Chem. 284:26860-26870.
23. Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI. 2007. Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells. Blood. 109:2058-2065. (Pubitemid 46348206)
24. Hamann D, Eichler W, Fiebig H, van Lier RA. 1996. Conformational changes in CD45 upon monoclonal antibody crosslinking. Hybridoma. 15:11-16. (Pubitemid 26079720)
25. Heit B, Tavener S, Raharjo E, Kubes P. 2002. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol. 159:91-102. (Pubitemid 35191521)
26. Henderson NC, Sethi T. 2009. The regulation of inflammation by Galectin-3. Immunol Rev. 230:160-171.
27. Hernandez JD, Nguyen JT, He J, Wang W, Ardman B, Green JM, Fukuda M, Baum LG. 2006. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J Immunol. 177:5328-5336. (Pubitemid 44527605)
28. Hirashima M. 1999. Ecalectin as a T cell-derived eosinophil chemoattractant. Int Arch Allergy Immunol. 120 (Suppl. 1):7-10. (Pubitemid 29457352)
29. Hirashima M. 2000. Ecalectin/galectin-9, a novel eosinophil chemoattractant: Its function and production. Int Arch Allergy Immunol. 122 (Suppl. 1): 6-9. (Pubitemid 30326326)
30. Howard TH, Oresajo CO. 1985. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J Cell Biol. 101:1078-1085. (Pubitemid 16258234)
31. Kasai K, Hirabayashi J. 1996. Galectins: A family of animal lectins that decipher glycocodes. J Biochem. 119:1-8. (Pubitemid 26048050)
32. Kuijpers TW, Hoogerwerf M, Kuijpers KC, Schwartz BR, Harlan JM. 1992. Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and a CD18-independent way. J Immunol. 149: 998-1003.
33. Kuwabara I, Sano H, Liu FT. 2003. Functions of galectins in cell adhesion and chemotaxis. Methods Enzymol. 363:532-552. (Pubitemid 37267697)
34. La M, Cao TV, Cerchiaro G, Chilton K, Hirabayashi J, Kasai K, Oliani SM, Chernajovsky Y, Perretti M. 2003. A novel biological activity for galectin-1: Inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol. 163:1505-1515. (Pubitemid 37175097)
35. Leffler H, Barondes SH. 1986. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. J Biol Chem. 261:10119-10126. (Pubitemid 17221945)
36. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. 2004. Introduction to galectins. Glycoconj J. 19:433-440. (Pubitemid 38316516)
37. Leppanen A, Stowell S, Blix O, Cummings RD. 2005. Dimeric galectin-1 binds with high affinity to α2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. J Biol Chem. 280:5549-5562. (Pubitemid 40280033)
38. Malik RK, Ghurye RR, Lawrence-Watt DJ, Stewart HJ. 2009. Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a Pertussis toxin sensitive pathway. Glycobiology. 9(12):1402-1407.
39. Mambole A, Baruch D, Nusbaum P, Bigot S, Suzuki M, Lesavre P, Fukuda M, Halbwachs-Mecarelli L. 2008. The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J Biol Chem. 283:23627-23635.
40. Marth JD, Grewal PK. 2008. Mammalian glycosylation in immunity. Nat Rev Immunol. 8:874-887.
41. Matsumoto M, Shigeta A, Miyasaka M, Hirata T. 2008. CD43 plays both antiadhesive and proadhesive roles in neutrophil rolling in a context-dependent manner. J Immunol. 181:3628-3635.
42. Nathan C, Xie QW, Halbwachs-Mecarelli L, Jin WW. 1993. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol. 122:243-256. (Pubitemid 23188815)
43. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG. 2001. CD45 modulates galectin-1-induced T cell death: Regulation by expression of core 2 O-glycans. J Immunol. 167:5697-5707. (Pubitemid 33062760)
44. Nieminen J, St-Pierre C, Bhaumik P, Poirier F, Sato S. 2008. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J Immunol. 180:2466-2473.
45. Norling LV, Peretti M, Cooper D. 2009. Endogenous galectins and the control of host inflammatory response. J Endocrinol. 201:169-184.
46. Pace KE, Hahn HP, Baum LG. 2003. Preparation of recombinant human galectin-1 and use in T-cell death assays. Methods Enzymol. 363: 499-518. (Pubitemid 37267694)
47. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. 1995. Apoptosis of T cells mediated by galectin-1. Nature. 378:736-739. (Pubitemid 126647279)
48. Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG. 1997. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med. 185:1851-1858. (Pubitemid 27242206)
49. Perone MJ, Bertera S, Shufesky WJ, Divito SJ, Montecalvo A, Mathers AR, Larregina AT, Pang M, Seth N, Wucherpfennig KW, et al. 2009. Suppression of autoimmune diabetes by soluble galectin-1. J Immunol. 182:2641-2653.
50. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM, Sotomayor CE. 1998. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization. J Immunol. 160:4831-4840. (Pubitemid 28215317)
51. Rabinovich GA, Rubinstein N, Fainboim L. 2002a. Unlocking the secrets of galectins: A challenge at the frontier of glyco-immunology. J Leukoc Biol. 71:741-752.
52. Rabinovich GA, Rubinstein N, Toscano MA. 2002b. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta. 1572:274-284. (Pubitemid 35246350)
53. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG. 2000. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol. 30:1331-1339. (Pubitemid 30311962)
54. Rabinovich GA, Toscano MA, Ilarregui JM, Rubinstein N. 2004. Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses. Glycoconj J. 19:565-573. (Pubitemid 38316531)
55. Remold-O'Donnell E, Davis AE, 3rd, Kenney D, Bhaskar KR, Rosen FS. 1986. Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Biol Chem. 261:7526-7530. (Pubitemid 17224761)
56. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B, Rosen FS. 1984. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med. 159:1705-1723. (Pubitemid 14117078)
57. Remold-O'Donnell E, Kenney D, Rosen FS. 1987. Biosynthesis of human sialophorins and analysis of the polypeptide core. Biochemistry. 26:3908-3913. (Pubitemid 17127460)
58. Remold-O'Donnell E, Parent D. 1994. Two proteolytic pathways for downregulation of the barrier molecule CD43 of human neutrophils. J Immunol. 152:3595-3605. (Pubitemid 24098057)
59. Remold-O'Donnell E, Rosen FS. 1990. Proteolytic fragmentation of sialophorin (CD43). Localization of the activation-inducing site and examination of the role of sialic acid. J Immunol. 145:3372-3378.
60. Rieu P, Porteu F, Bessou G, Lesavre P, Halbwachs-Mecarelli L. 1992. Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur J Immunol. 22:3021-3026.
61. Rubinstein N, Ilarregui JM, toscano M, Rabinovich GA. 2004. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue antigens. 64:1-12. (Pubitemid 38850363)
62. Sangeetha SR, Appukuttan PS. 2005. IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1->3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand. Int J Biol Macromol. 35:269-276. (Pubitemid 40615989)
63. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashim M, Liu FT. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol. 165:2156-2164. (Pubitemid 30643165)
64. Sato S, St-Pierre C, Bhaumik P, Nieminen J. 2009. Galectins in innate immunity: Dual functions of host soluble beta-galactoside-binding lectins as damageassociated molecular patterns (DAMPs) and as receptors for pathogenassociated molecular patterns (PAMPs). Immunol Rev. 230:172-187.
65. Savage ND, Kimzey SL, Bromley SK, Johnson KG, Dustin ML, Green JM. 2002. Polar redistribution of the sialoglycoprotein CD43: Implications for T cell function. J Immunol. 168:3740-3746. (Pubitemid 34298372)
66. Seelenmeyer C, Wegehingel S, Tews I, Kunzler M, Aebi M, Nickel W. 2005. Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol. 171:373-381. (Pubitemid 41540028)
67. Selvatici R, Falzarano S, Mollica A, Spisani S. 2006. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol. 534:1-11. (Pubitemid 43384177)
68. Serrador JM, Nieto M, Alonso-Lebrero JL, del Pozo MA, Calvo J, Furthmayr H, Schwartz-Albiez R, Lozano F, Gonzalez-Amaro R, Sanchez-Mateos P, et al. 1998. CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood. 91:4632-4644. (Pubitemid 28270312)
69. Seveau S, Keller H, Maxfield FR, Piller F, Halbwachs-Mecarelli L. 2000. Neutrophil polarity and locomotion are associated with surface redistribution of leukosialin (CD43), an antiadhesive membrane molecule. Blood. 95:2462-2470. (Pubitemid 30210520)
70. Stefanova I, Hilgert I, Angelisova P, Kristofova H, Horejsi V. 1988. Characterization of a 95 kDa human leucocyte sialoglycoprotein: Its identity with CD43, gpL115, leukosialin and sialophorin. Folia Biol (Praha). 34:255-265.
71. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG. 2006. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol. 176:778-789. (Pubitemid 43099674)
72. Stowell SR, Karmakar S, Arthur CM, Ju T, Rodrigues LC, Riul TB, Dias-Baruffi M, Miner J, McEver RP, Cummings RD. 2009. Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol Biol Cell. 20:1408-1418.
73. Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD. 2007. Human galectin-1,-2, and-4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood. 109:219-227. (Pubitemid 46053062)
74. Stross WP, Warnke RA, Flavell DJ, Flavell SU, Simmons D, Gatter KC, Mason DY. 1989. Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. J Clin Pathol. 42:953-961. (Pubitemid 19225457)
75. Thomas ML. 1989. The leukocyte common antigen family. Annu Rev Immunol. 7:339-369. (Pubitemid 19138017)
76. Tkaczuk J, Al Saati T, Escargueil-Blanc I, Salvayre A, Horejsi V, Durand M, de Preval C, Ohayon E, Delsol G, Abbal M. 1999. The CBF.78 monoclonal antibody to human sialophorin has distinct properties giving new insights into the CD43 marker and its activation pathway. Tissue Antigens. 54:1-15. (Pubitemid 29326925)
77. van Kooyk Y, Rabinovich GA. 2008. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol. 9:593-601. (Pubitemid 351712630)
78. Wallace PJ, Wersto RP, Packman CH, Lichtman MA. 1984. Chemotactic peptide-induced changes in neutrophil actin conformation. J Cell Biol. 99:1060-1065. (Pubitemid 14043363)
79. Woodman RC, Johnston B, Hickey MJ, Teoh D, Reinhardt P, Poon BY, Kubes P. 1998. The functional paradox of CD43 in leukocyte recruitment: A study using CD43-deficient mice. J Exp Med. 188:2181-2186. (Pubitemid 28562534)
80. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S. 1998. Ezrin/ radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol. 140:885-895. (Pubitemid 28141226)